AIDOT Signs $1.7 Million Annual Collaboration Agreement with Vietnamese Company SNET VINA for AI Cervical Cancer Screening “Cerviray AI”

AI-based medical company AIDOT (CEO Jung Jae-hoon, formerly Buzzpole) announced on the 15th that it has signed a mutual cooperation agreement with Vietnamese company SNET VINA for joint market entry of its AI cervical cancer screening solution, “Cerviray AI,” with an annual contract value of $1.7 million (approximately KRW 1.95 billion).

Despite high demand for cervical cancer screening in Vietnam, the testing rate remains relatively low at 6.5% compared with other cancer screenings, largely due to the lack of accessible methods. Most current screening options, such as ultrasound or tissue biopsy, are expensive for the general population. AIDOT’s Cerviray AI is expected to address these issues by providing an efficient, AI-based alternative.

Building on the fast and accurate references established through the commercialization of Cerviray AI in China, the agreement aims to implement an effective AI-based cervical cancer screening system in the Vietnamese market.

CEO Jung Jae-hoon of AIDOT said, “We are pleased to pioneer the Southeast Asian market through the differentiated corporate matching program of the Institute for Information & Communications Technology Promotion (IITP),” adding, “This collaboration will also allow us to supply additional AI medical solutions to the Southeast Asian market.”

He continued, “This cooperation represents a major achievement in the field of AI medical ICT, combining the expertise of top Korean medical professionals,” and praised the Korean government’s efforts to support startups in expanding overseas.

AI Times / Reporter Jung Han-young
Published: October 15, 2020, 18:33